Gynecologic Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Gynecologic
| Protocol | NRG-GY037 |
|---|---|
| Cancer Type: | Cervical Cancer |
| Fast Facts |
NRG-GY037: A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG-GY025 |
|---|---|
| Cancer Type: | Endometrial carcinoma or carcinosarcoma |
| Fast Facts |
NRG-GY025: A Randomized Phase II Trial of Nivolumab and Ipilimumab Compared to Nivolumab Monotherapy in Patients with Deficient Mismatch Repair System Recurrent Endometrial Carcinoma
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
